TimesSquare Capital Management, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
TimesSquare Capital Management, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$67,549,000
+4.5%
392,500
-23.8%
0.59%
+11.5%
Q2 2021$64,627,000
-28.6%
514,995
-22.8%
0.53%
-31.7%
Q1 2021$90,453,000
-10.3%
667,010
-15.3%
0.78%
-5.4%
Q4 2020$100,811,000
+5.2%
787,955
-7.5%
0.82%
-8.7%
Q3 2020$95,859,000
+3.0%
851,855
-12.8%
0.90%
+1.1%
Q2 2020$93,024,000
+3.6%
976,420
-2.3%
0.89%
-17.2%
Q1 2020$89,809,000
+50.5%
999,320
-11.2%
1.07%
+101.3%
Q4 2019$59,678,000
+44.0%
1,125,575
+7.3%
0.53%
+45.0%
Q3 2019$41,442,000
+10.0%
1,048,900
+14.4%
0.37%
+26.6%
Q2 2019$37,669,000
-12.1%
916,970
-0.4%
0.29%
-12.1%
Q1 2019$42,878,000
+38.5%
920,715
+29.5%
0.33%
+23.6%
Q4 2018$30,956,000
-26.7%
710,815
-3.7%
0.27%
-4.6%
Q3 2018$42,242,000
+131.1%
738,115
+96.0%
0.28%
+129.5%
Q2 2018$18,275,000
+40.8%
376,655
+13.4%
0.12%
+38.6%
Q1 2018$12,981,000332,0050.09%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 917,767$52,524,0008.19%
Foresite Capital Management II, LLC 220,268$12,606,0004.66%
Foresite Capital Management III, LLC 250,863$14,357,0003.17%
Novo Holdings A/S 650,000$37,200,0002.95%
QVT Financial LP 190,977$10,930,0002.82%
Perceptive Advisors 1,528,205$87,459,0002.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,117,651$63,963,0002.29%
Asymmetry Capital Management, L.P. 39,912$2,284,0002.11%
SECTORAL ASSET MANAGEMENT INC 298,726$17,096,0001.82%
Stanley-Laman Group, Ltd. 125,020$7,155,0001.76%
View complete list of ACCELERON PHARMA INC shareholders